PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers
This partially randomized pilot clinical trial develops and studies a software program, called PatientCareAnywhere, to see whether it can help patients communicate with their doctors and other healthcare providers, and educate themselves about their cancer and treatment options. A program that can help patients learn about their cancer and treatment options, and allows the patient's healthcare providers to receive their questionnaire results, may help patients identify and get help to treat their symptoms.
Checked against the public recordLast updated Jun 27, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- City of Hope Medical Center
- Interventions being studied
- Other: Communication Intervention; Other: Educational Intervention; Other: Internet-Based Intervention; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * PHASE I AIM 1 (STAKEHOLDER INPUT) * PHASE I AIM 1: Malignant diagnosis in any cancer type at any stage * PHASE I AIM 1: Receiving any type of cancer treatment * PHASE I AIM 1: Life expectancy of at least six months * PHASE I AIM 1: Current outpatient status * PHASE I AIM 1: Fluent in English * PHASE I AIM 1: Internet access at home * PHASE I AIM 3.1 (EVALUATION STUDY) * PHASE I AIM 3.1: Malignant diagnosis in any cancer type at any stage * PHASE I AIM 3.1: Receiving any type of cancer treatment * PHASE I AIM 3.1: Life expectancy of at least six months * PHASE I AIM 3.1: Current outpatient status * PHASE I AIM 3.1: Fluent in English * PHASE I AIM 3.1: Internet access at home * PHASE I AIM 3.2 (PILOT STUDY) * PHASE I AIM 3.2: Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage * PHASE I AIM 3.2: Receiving surgery and/or chemotherapy treatment * PHASE I AIM 3.2: Life expectancy of at least six months * PHASE I AIM 3.2: Current outpatient status (participation will be suspended during hospitalization) * PHASE I AIM 3.2: Fluent in English * PHASE I AIM 3.2: Internet access at home * PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) * PHASE II AIM 2: Malignant diagnosis of breast, lung, or colorectal cancer at any stage * PHASE II AIM 2: Receiving any type of cancer treatment * PHASE II AIM 2: Life expectancy of at least six months * PHASE II AIM 2: Current medical oncology outpatient status (participation will be suspended during hospitalization) * PHASE II AIM 2: Fluent in English * PHASE II AIM 2: Internet access at home Exclusion Criteria: * PHASE I AIM 1 (STAKEHOLDER INPUT) EXCLUSION * PHASE I AIM 1: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 1: Prisoners and pregnant women * PHASE I AIM 3.1 (EVALUATION STUDY) EXCLUSION * PHASE I AIM 3.1: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 3.1: Prisoners and pregnant women * PHASE I AIM 3.2 (PILOT STUDY) EXCLUSION * PHASE I AIM 3.2: Clinical evidence of cognitive or psychological impairment * PHASE I AIM 3.2: Prisoners and pregnant women * PHASE I AIM 3.2: Currently participating in other psychosocial studies * PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) EXCLUSION * PHASE II AIM 2: Clinical evidence of cognitive or psychological impairment * PHASE II AIM 2: Prisoners and pregnant women * PHASE II AIM 2: Currently participating in other psychosocial studies
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- City of Hope Medical CenterDuarte, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 27, 2024. Always confirm current availability with the study team.